Association between VEGF-460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.

about

Addition of bevacizumab to systemic therapy for locally advanced and metastatic nasopharyngeal carcinoma.

P2860

Q55025647-08B963F8-F2F8-43AF-B465-858A5AEAD7F9

P2860

Association between VEGF-460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.

Item

http://www.wikidata.org/entity/Q41991817

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Association between VEGF-460T/ ...... y-modulated radiation therapy.

@en

type

Item

label

Association between VEGF-460T/ ...... y-modulated radiation therapy.

@en

prefLabel

Association between VEGF-460T/ ...... y-modulated radiation therapy.

@en

P1476

Association between VEGF-460T/ ...... y-modulated radiation therapy.

@en

P2093

Chunlin Wang

http://www.w3.org/2001/XMLSchema#string

Dongmei Xia

http://www.w3.org/2001/XMLSchema#string

Jingshan Chen

http://www.w3.org/2001/XMLSchema#string

Junyin Tan

http://www.w3.org/2001/XMLSchema#string

Li Jiang

http://www.w3.org/2001/XMLSchema#string

Peng Xie

http://www.w3.org/2001/XMLSchema#string

Rensheng Wang

http://www.w3.org/2001/XMLSchema#string

Xiaoqing Huang

http://www.w3.org/2001/XMLSchema#string

Xiaowei Cheng

http://www.w3.org/2001/XMLSchema#string

Yong Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG).

Significant benefits of adding neoadjuvant chemotherapy before concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trials.

Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy.

Vascular endothelial growth factor and the regulation of angiogenesis.

Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models.

Vascular endothelial growth factor: basic science and clinical progress.

Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy

Antitumor activity of Endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft models.

Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study

Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.

P304

909-918

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S126159

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28243126

http://www.w3.org/2001/XMLSchema#string

P932

5317327

http://www.w3.org/2001/XMLSchema#string

Association between VEGF-460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.

about

P2860

P2860

Association between VEGF-460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932